https://www.selleckchem.com/products/AM-1241.html
Background"Rare subgroups of pediatric patients with acute myeloid leukemia (AML), such as t(1621) (p11;q22), require international cooperation to establish a proper stratification system to assign clinical risk. Here, we report a 13-year-old female who was admitted for asthenia, fatigue, and intermittent fever. The hematological data showed thrombocytopenia and anemia, and the bone marrow test showed 82.5% blast cells, which were positive for CD13, CD33, CD38, and CD117. Blast cells showed negative myeloperoxidase staining and posi
Like
Comment
Share
